As of 2025-07-03, the Relative Valuation of Keros Therapeutics Inc (KROS) is 3.80 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.41 USD, the upside of Keros Therapeutics Inc based on Relative Valuation is -71.7%.
The range of the Relative Valuation is 2.79 - 5.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.9x - 33.0x | 30.0x |
| Forward P/E multiples | 32.5x - 54.2x | 43.4x |
| Fair Price | 2.79 - 5.62 | 3.80 |
| Upside | -79.2% - -58.1% | -71.7% |
| Date | P/E |
| 2025-07-02 | 130.87 |
| 2025-07-01 | 128.65 |
| 2025-06-30 | 128.75 |
| 2025-06-27 | 130.10 |
| 2025-06-26 | 130.29 |
| 2025-06-25 | 131.64 |
| 2025-06-24 | 132.22 |
| 2025-06-23 | 132.70 |
| 2025-06-20 | 130.10 |
| 2025-06-18 | 130.67 |
| 2025-06-17 | 129.81 |
| 2025-06-16 | 131.74 |
| 2025-06-13 | 130.77 |
| 2025-06-12 | 131.54 |
| 2025-06-11 | 132.99 |
| 2025-06-10 | 132.60 |
| 2025-06-09 | 135.88 |
| 2025-06-06 | 145.04 |
| 2025-06-05 | 145.72 |
| 2025-06-04 | 142.92 |
| 2025-06-03 | 144.18 |
| 2025-06-02 | 141.38 |
| 2025-05-30 | 136.46 |
| 2025-05-29 | 135.21 |
| 2025-05-28 | 141.19 |
| 2025-05-27 | 138.39 |
| 2025-05-23 | 140.51 |
| 2025-05-22 | 136.56 |
| 2025-05-21 | 135.40 |
| 2025-05-20 | 136.36 |
| 2025-05-19 | 135.98 |
| 2025-05-16 | 135.69 |
| 2025-05-15 | 135.30 |
| 2025-05-14 | 131.06 |
| 2025-05-13 | 129.90 |
| 2025-05-12 | 132.51 |
| 2025-05-09 | 131.64 |
| 2025-05-08 | 135.21 |
| 2025-05-07 | 132.22 |
| 2025-05-06 | 132.70 |
| 2025-05-05 | 140.37 |
| 2025-05-02 | 141.28 |
| 2025-05-01 | 140.51 |
| 2025-04-30 | 139.26 |
| 2025-04-29 | 139.35 |
| 2025-04-28 | 137.52 |
| 2025-04-25 | 137.04 |
| 2025-04-24 | 139.06 |
| 2025-04-23 | 137.91 |
| 2025-04-22 | 133.95 |